Does vascular occlusion in liver resections predispose to recurrence of malignancy in the liver remnant due to ischemia/reperfusion injury? A comparative retrospective cohort study.


Journal

International journal of surgery (London, England)
ISSN: 1743-9159
Titre abrégé: Int J Surg
Pays: United States
ID NLM: 101228232

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 25 02 2020
revised: 18 05 2020
accepted: 04 06 2020
pubmed: 4 7 2020
medline: 22 12 2020
entrez: 4 7 2020
Statut: ppublish

Résumé

Severe ischemic changes of the liver remnant after hepatectomy could expedite tumor recurrence on the residual liver. Our study aimed at assessing the effect of warm ischemic/reperfusion (I/R) injuries on surgery-to-local recurrence interval and patient overall survival, during major hepatectomies under inflow and outflow vascular control. One hundred and eighteen patients were subjected to liver resection under total inflow and outflow vascular clamping and were assigned as study group. These individuals were retrospectively matched to 112 counterparts, who underwent liver surgery applying inflow and outflow vascular clamping only of the segment harboring the tumor, sparing the liver remnant from any I/R injury (control group). The two cohorts were compared regarding recurrence-free survival and overall survival. Reversible I/R injuries of the liver remnant subjected to vascular clamping were manifested, with increase of AST values at postoperative day 2 in the study group, as compared to the control group (603 ± 270 U/L vs. 450 ± 290 U/L, p < 0.001), reversing to normal by day 7. Recurrence-free survival and overall survival were no significantly different between the two groups (log rank statistic p = 0.298 and 0.639, respectively). Reversible I/R injuries of the liver remnant do not seem to be implicated in the precipitation of local malignant recurrence or in shorter long-term survival, in comparison to a technique sparing the residual liver of I/R injury. This retrospective cohort study was registered at clinicaltrials.gov under unique identifying number: NCT04257240.

Sections du résumé

BACKGROUND BACKGROUND
Severe ischemic changes of the liver remnant after hepatectomy could expedite tumor recurrence on the residual liver. Our study aimed at assessing the effect of warm ischemic/reperfusion (I/R) injuries on surgery-to-local recurrence interval and patient overall survival, during major hepatectomies under inflow and outflow vascular control.
METHODS METHODS
One hundred and eighteen patients were subjected to liver resection under total inflow and outflow vascular clamping and were assigned as study group. These individuals were retrospectively matched to 112 counterparts, who underwent liver surgery applying inflow and outflow vascular clamping only of the segment harboring the tumor, sparing the liver remnant from any I/R injury (control group). The two cohorts were compared regarding recurrence-free survival and overall survival.
RESULTS RESULTS
Reversible I/R injuries of the liver remnant subjected to vascular clamping were manifested, with increase of AST values at postoperative day 2 in the study group, as compared to the control group (603 ± 270 U/L vs. 450 ± 290 U/L, p < 0.001), reversing to normal by day 7. Recurrence-free survival and overall survival were no significantly different between the two groups (log rank statistic p = 0.298 and 0.639, respectively).
CONCLUSION CONCLUSIONS
Reversible I/R injuries of the liver remnant do not seem to be implicated in the precipitation of local malignant recurrence or in shorter long-term survival, in comparison to a technique sparing the residual liver of I/R injury. This retrospective cohort study was registered at clinicaltrials.gov under unique identifying number: NCT04257240.

Identifiants

pubmed: 32619621
pii: S1743-9191(20)30501-X
doi: 10.1016/j.ijsu.2020.06.019
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT04257240']

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

68-73

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Kassiani Theodoraki (K)

1st Department of Anesthesiology, School of Medicine, National and Kapodistrian University of Athens, "Aretaieion" Hospital, Athens, Greece. Electronic address: ktheodoraki@hotmail.com.

Maria Papadoliopoulou (M)

4th Department of Surgery, School of Medicine, National and Kapodistrian University of Athens, "Attikon" Hospital, Athens, Greece.

Zoe Petropoulou (Z)

4th Department of Surgery, School of Medicine, National and Kapodistrian University of Athens, "Attikon" Hospital, Athens, Greece.

Theodosios Theodosopoulos (T)

2nd Department of Surgery, School of Medicine, National and Kapodistrian University of Athens, "Aretaieion" Hospital, Athens, Greece.

Pantelis Vassiliu (P)

4th Department of Surgery, School of Medicine, National and Kapodistrian University of Athens, "Attikon" Hospital, Athens, Greece.

Andreas Polydorou (A)

2nd Department of Surgery, School of Medicine, National and Kapodistrian University of Athens, "Aretaieion" Hospital, Athens, Greece.

Pantelis Xanthakos (P)

4th Department of Surgery, School of Medicine, National and Kapodistrian University of Athens, "Attikon" Hospital, Athens, Greece.

George Fragulidis (G)

2nd Department of Surgery, School of Medicine, National and Kapodistrian University of Athens, "Aretaieion" Hospital, Athens, Greece.

Vassilios Smyrniotis (V)

4th Department of Surgery, School of Medicine, National and Kapodistrian University of Athens, "Attikon" Hospital, Athens, Greece.

Nikolaos Arkadopoulos (N)

4th Department of Surgery, School of Medicine, National and Kapodistrian University of Athens, "Attikon" Hospital, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH